Skip to main content

News & Press Releases

Filter by:

Insights-card-Press-Release

Mintz celebrates the 20th anniversary of its San Diego office opening, marking two decades of impact across the region’s business, civic, and nonprofit communities. The milestone reflects the firm’s longstanding presence in San Diego and reaffirms its commitment to the region’s innovation economy. The firm’s contributions have also been recognized by the City of San Diego, which recently proclaimed June 6 as “Mintz Day” in honor of its impact across the business and civic communities it serves.

Insights-card-Press-Release

Mintz earned recognition for 43 practices and 85 attorneys in the 2026 edition of Chambers USA. Among this year’s results, 14 attorneys and six practice areas received Chambers’ highest distinction, Band 1. Mintz Insurance Practice Chair Nancy Adams was also named a “Star Individual,” a rare designation awarded to lawyers with exceptional recommendations in their field. The firm further expanded its rankings with newly recognized practices and attorneys ranked for the first time or in additional categories.

Insights-card-Press-Release

Mintz is advising the placement agents in connection with the $215 million private placement that is expected to close concurrently with the completion of the merger transaction between Avenzo Therapeutics, Inc. and Rallybio Corporation.

Insights-card-Press-Release

Mintz Member Terri Shieh-Newton, PhD, has been named to Forbes’ inaugural 2026 America’s Top Women Lawyers list. The list recognizes women in private practice who have built elite reputations through high-stakes legal work, client impact, and leadership across the profession.

Insights-card-Press-Release

Mintz’s Intellectual Property Practice earned national recognition in the 2026 edition of IAM Patent 1000: The World’s Leading Patent Practitioners. The guide recognizes Mintz with four firmwide rankings and 17 individual attorney distinctions, including a gold ranking for Michael Renaud, who leads the firm’s IP Division.

Insights-card-Press-Release

Mintz advised the underwriters in connection with NervGen Pharma’s $60 million public offering of common shares and accompanying warrants.

Kerri Chace headshot
Press Contact

Kerri Chace

Associate Director, Communications

[email protected]
|
1.617.348.1671

Follow Mintz